OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SMAC Mimetics as Therapeutic Agents in HIV Infection
Bengisu Molyer, Ashok Kumar, Jonathan B. Angel
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 15
Bengisu Molyer, Ashok Kumar, Jonathan B. Angel
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 15
Showing 15 citing articles:
Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in latency
Alexandra Dorman, Maryam Bendoumou, Aurelija Valaitienė, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Alexandra Dorman, Maryam Bendoumou, Aurelija Valaitienė, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure
Natasha N. Duggan, Tatjana Dragic, Sumit K. Chanda, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2435-2435
Open Access | Times Cited: 14
Natasha N. Duggan, Tatjana Dragic, Sumit K. Chanda, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2435-2435
Open Access | Times Cited: 14
Advances in structure-activity relationships of HDAC inhibitors as HIV latency-reversing agents
Samima Khatun, Sk. Abdul Amin, Debasmita Choudhury, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 3, pp. 353-368
Closed Access | Times Cited: 5
Samima Khatun, Sk. Abdul Amin, Debasmita Choudhury, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 3, pp. 353-368
Closed Access | Times Cited: 5
Latency Reversing Agents and the Road to a HIV Cure
Louis Tioka, Rafael Ceña-Díez, Anders Sönnerborg, et al.
Pathogens (2025) Vol. 14, Iss. 3, pp. 232-232
Open Access
Louis Tioka, Rafael Ceña-Díez, Anders Sönnerborg, et al.
Pathogens (2025) Vol. 14, Iss. 3, pp. 232-232
Open Access
Synergistic Activity of Second Mitochondrial-Derived Activator of Caspases Mimetic with Toll-like Receptor 8 Agonist Reverses HIV-1-Latency and Enhances Antiviral Immunity
Killian E. Vlaming, Jade Jansen, Godelieve J. de Bree, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2575-2575
Open Access
Killian E. Vlaming, Jade Jansen, Godelieve J. de Bree, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2575-2575
Open Access
ABT-263, a BCL-2 inhibitor, selectively eliminates latently HIV-1-infected cells without viral reactivation
Jeong Eun Kang, Hyun Wook Seo, Dong‐Eun Kim, et al.
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0322962-e0322962
Open Access
Jeong Eun Kang, Hyun Wook Seo, Dong‐Eun Kim, et al.
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0322962-e0322962
Open Access
HIV-1 transcriptional modulation: novel host factors and prospective therapeutic strategies
Quentin M. R. Gibaut, Luisa Mori, Susana T. Valente
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 5, pp. 264-272
Closed Access | Times Cited: 6
Quentin M. R. Gibaut, Luisa Mori, Susana T. Valente
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 5, pp. 264-272
Closed Access | Times Cited: 6
Noncanonical-NF-κB activation and DDX3 inhibition reduces the HIV-1 reservoir by elimination of latently infected cells ex-vivo
Jade Jansen, Stefanie Kroeze, S. F. Paul Man, et al.
Microbiology Spectrum (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Jade Jansen, Stefanie Kroeze, S. F. Paul Man, et al.
Microbiology Spectrum (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Targeting Viral Transcription for HIV Cure Strategies
Jon Izquierdo-Pujol, María C. Puertas, Javier Martínez‐Picado, et al.
Microorganisms (2024) Vol. 12, Iss. 4, pp. 752-752
Open Access | Times Cited: 1
Jon Izquierdo-Pujol, María C. Puertas, Javier Martínez‐Picado, et al.
Microorganisms (2024) Vol. 12, Iss. 4, pp. 752-752
Open Access | Times Cited: 1
HIV associated cell death: Peptide-induced apoptosis restricts viral transmission
Qiongyu Chen, Yan Zhao, Yonghong Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Qiongyu Chen, Yan Zhao, Yonghong Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Soluble CD4 and low molecular weight CD4-mimetic compounds sensitize cells to be killed by anti-HIV cytotoxic immunoconjugates
Seth H. Pincus, M A Stackhouse, Connie Watt, et al.
Journal of Virology (2023) Vol. 97, Iss. 10
Open Access | Times Cited: 3
Seth H. Pincus, M A Stackhouse, Connie Watt, et al.
Journal of Virology (2023) Vol. 97, Iss. 10
Open Access | Times Cited: 3
Identification of Anti-gp41 Monoclonal Antibodies That Effectively Target Cytotoxic Immunoconjugates to Cells Infected with Human Immunodeficiency Virus, Type 1
Grant Klug, Frances M. Cole, Mark D. Hicar, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 829-829
Open Access | Times Cited: 2
Grant Klug, Frances M. Cole, Mark D. Hicar, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 829-829
Open Access | Times Cited: 2
An orally-available monovalent SMAC mimetic compound as a broad-spectrum antiviral
Miao Mei, Maria Antonietta Impagnatiello, Jun Jiao, et al.
Protein & Cell (2023) Vol. 15, Iss. 1, pp. 69-75
Open Access | Times Cited: 1
Miao Mei, Maria Antonietta Impagnatiello, Jun Jiao, et al.
Protein & Cell (2023) Vol. 15, Iss. 1, pp. 69-75
Open Access | Times Cited: 1
Conjugation of anti-HIV gp41 monoclonal antibody to a drug capable of targeting resting lymphocytes produces an effective cytotoxic anti-HIV immunoconjugate
Seth H. Pincus, Frances M. Cole, Kelli Ober, et al.
Journal of Virology (2024) Vol. 98, Iss. 10
Closed Access
Seth H. Pincus, Frances M. Cole, Kelli Ober, et al.
Journal of Virology (2024) Vol. 98, Iss. 10
Closed Access
Retinoids: novel potential therapeutics in the pursuit of HIV-1 cure
Andrew Purssell, Michaeline McGuinty, Branka Vulesevic, et al.
Frontiers in Virology (2022) Vol. 2
Open Access | Times Cited: 2
Andrew Purssell, Michaeline McGuinty, Branka Vulesevic, et al.
Frontiers in Virology (2022) Vol. 2
Open Access | Times Cited: 2
The SMAC mimetic birinapant alleviates lipopolysaccharide-induced acute lung injury by inhibiting MAPK signaling
Hui Hu, Man Ma, Tao Li, et al.
Immunology Letters (2023) Vol. 264, pp. 31-35
Closed Access
Hui Hu, Man Ma, Tao Li, et al.
Immunology Letters (2023) Vol. 264, pp. 31-35
Closed Access
